Patent 9393367 was granted and assigned to Antares Pharma Inc. on July, 2016 by the United States Patent and Trademark Office.
The present disclosure relates, in part, to a kit including at least two prefilled syringes. The first prefilled syringe includes a dose of a hazardous agent in a first volume of a pharmaceutical composition comprising a pharmaceutically acceptable solvent.